To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

How to transfigure the Wikipedia

Would you like Wikipedia to always look as professional and up-to-date? We have created a browser extension. It will enhance any encyclopedic page you visit with the magic of the WIKI 2 technology.

Try it — you can delete it anytime.

Install in 5 seconds
4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
Great Wikipedia has got greater.
.
Leo
Newton
Brights
Milds

Refanezumab

From Wikipedia, the free encyclopedia

Refanezumab
Monoclonal antibody
Type?
SourceHumanized (from mouse)
Targetmyelin-associated glycoprotein
Clinical data
Other namesGSK249320
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6608H10156N1732O2064S44
Molar mass148298.64 g·mol−1

Refanezumab (GSK249320) is a monoclonal antibody designed for the recovery of motor function after stroke.[1][2]

This drug was developed by GlaxoSmithKline.

References

  1. ^ "Refanezumab" (PDF). Statement On A Nonproprietary Name Adopted By The USAN Council. American Medical Association..
  2. ^ Cramer SC, Enney LA, Russell CK, Simeoni M, Thompson TR (March 2017). "Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients". Stroke. 48 (3): 692–698. doi:10.1161/STROKEAHA.116.014517. PMC 5325241. PMID 28228578.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

This page was last edited on 26 September 2023, at 14:21
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.
Contact WIKI 2
Introduction
Terms of Service
Privacy Policy